Anna A. Emelianova

703 total citations · 1 hit paper
7 papers, 590 citations indexed

About

Anna A. Emelianova is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Anna A. Emelianova has authored 7 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Microbiology and 2 papers in Immunology. Recurrent topics in Anna A. Emelianova's work include Antimicrobial Peptides and Activities (4 papers), Invertebrate Immune Response Mechanisms (2 papers) and Biochemical and Structural Characterization (2 papers). Anna A. Emelianova is often cited by papers focused on Antimicrobial Peptides and Activities (4 papers), Invertebrate Immune Response Mechanisms (2 papers) and Biochemical and Structural Characterization (2 papers). Anna A. Emelianova collaborates with scholars based in Russia and Belgium. Anna A. Emelianova's co-authors include Denis Kuzmin, Anton Buzdin, Maxim Sorokin, Pieter Borger, Marianna Zolotovskaia, Nikolay Borisov, Andrew Garazha, Tatiana V. Ovchinnikova, Pavel V. Panteleev and Ilia A. Bolosov and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Microbiology and Frontiers in Pharmacology.

In The Last Decade

Anna A. Emelianova

7 papers receiving 585 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs

2019 467 citations Marianna Zolotovskaia, Maxim Sorokin et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna A. Emelianova Russia	6	256	87	60	48	43	7	590
Xiaozhen Guo China	13	247 1.0×	39 0.4×	68 1.1×	88 1.8×	37 0.9×	26	747
Georgiana Nițulescu Romania	13	376 1.5×	25 0.3×	50 0.8×	77 1.6×	44 1.0×	28	819
Tong Li China	19	376 1.5×	30 0.3×	70 1.2×	50 1.0×	94 2.2×	83	1.1k
Jestin Chellian Malaysia	16	275 1.1×	18 0.2×	53 0.9×	54 1.1×	56 1.3×	31	799
Ahmed M. Atwa Egypt	14	182 0.7×	25 0.3×	27 0.5×	21 0.4×	49 1.1×	53	503
Hye Jin Park South Korea	16	154 0.6×	79 0.9×	19 0.3×	103 2.1×	17 0.4×	44	766
Hideshi Natsume Japan	17	368 1.4×	22 0.3×	54 0.9×	93 1.9×	65 1.5×	68	1.0k
Mohammad Reza Hajizadeh Iran	17	251 1.0×	21 0.2×	38 0.6×	85 1.8×	43 1.0×	71	672
Smirnov Vv Russia	14	258 1.0×	20 0.2×	46 0.8×	27 0.6×	90 2.1×	116	636

Countries citing papers authored by Anna A. Emelianova

Since Specialization

Citations

This map shows the geographic impact of Anna A. Emelianova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna A. Emelianova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna A. Emelianova more than expected).

Fields of papers citing papers by Anna A. Emelianova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna A. Emelianova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna A. Emelianova. The network helps show where Anna A. Emelianova may publish in the future.

Co-authorship network of co-authors of Anna A. Emelianova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna A. Emelianova. A scholar is included among the top collaborators of Anna A. Emelianova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna A. Emelianova. Anna A. Emelianova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Rozenberg, Julian M., et al.. (2024). Forced Overexpression and Knockout Analysis of SLC30A and SLC39A Family Genes Suggests Their Involvement in Establishing Resistance to Cisplatin in Human Cancer Cells. International Journal of Molecular Sciences. 25(22). 12049–12049. 1 indexed citations

2.

Rozenberg, Julian M., et al.. (2024). Recent advances and fundamentals of microalgae cultivation technology. Biotechnology Journal. 19(3). e2300725–e2300725. 15 indexed citations

3.

Zolotovskaia, Marianna, Maxim Sorokin, Anna A. Emelianova, et al.. (2019). Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs. Frontiers in Pharmacology. 10. 1–1. 467 indexed citations breakdown →

4.

Panteleev, Pavel V., Ilia A. Bolosov, V. N. Kokryakov, et al.. (2018). Combined Antibacterial Effects of Goat Cathelicidins With Different Mechanisms of Action. Frontiers in Microbiology. 9. 2983–2983. 32 indexed citations

5.

Panteleev, Pavel V., Anna A. Emelianova, Maxim Sorokin, et al.. (2018). Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III. Marine Drugs. 16(12). 466–466. 24 indexed citations

6.

Emelianova, Anna A., Denis Kuzmin, Pavel V. Panteleev, et al.. (2018). Anticancer Activity of the Goat Antimicrobial Peptide ChMAP-28. Frontiers in Pharmacology. 9. 1501–1501. 26 indexed citations

7.

Kuzmin, Denis, Anna A. Emelianova, Pavel V. Panteleev, et al.. (2017). Comparative in vitro study on cytotoxicity of recombinant β‐hairpin peptides. Chemical Biology & Drug Design. 91(1). 294–303. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact